Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pohl

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|November 1, 1975
[Changes in the munber of 60-year old and older internal patients during a period of 10 years]W Heidel, W Beinroth, K Dachselt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor moleculeA Hombach, A Wieczarkowiecz, T Marquardt, et al.
Anticancer Research|May 1, 1997
Activation of resting T cells against the CA 72-4 tumor antigen with an anti-CD3/CA 72-4 bispecific antibody in combination with a costimulatory anti-CD28 antibodyA Hombach, S Mathas, M Jensen, et al.
Clinical and Experimental Immunology|May 1, 1997
Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicityA Hombach, T Tillmann, M Jensen, et al.
Lymphokine and Cytokine Research|April 1, 1992
Increased levels of circulating cytokines in patients with untreated Hodgkin's diseaseA Gause, S Keymis, R Scholz, et al.
Cancer Research|March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysisA Hombach, D Sent, C Schneider, et al.
Gastroenterology|October 10, 1997
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitopeA Hombach, C Heuser, R Sircar, et al.
Journal of Chromatography. A|January 23, 1999
Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phasesM Weitzhandler, D Farnan, J Horvath, et al.
Plos Neglected Tropical Diseases|February 10, 2025
Investigating the impact of Premolis semirufa caterpillar bristle toxins on human chondrocyte activation and inflammationCinthya Lais de Lima, Paula C Pohl, Isadora M Villas-Boas, et al.
ACS Synthetic Biology|April 14, 2016
CRISPR/Cas9 Based Genome Editing of Penicillium chrysogenumC Pohl, J A K W Kiel, A J M Driessen, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|November 1, 1975
[Changes in the munber of 60-year old and older internal patients during a period of 10 years]W Heidel, W Beinroth, K Dachselt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor moleculeA Hombach, A Wieczarkowiecz, T Marquardt, et al.
Anticancer Research|May 1, 1997
Activation of resting T cells against the CA 72-4 tumor antigen with an anti-CD3/CA 72-4 bispecific antibody in combination with a costimulatory anti-CD28 antibodyA Hombach, S Mathas, M Jensen, et al.
Clinical and Experimental Immunology|May 1, 1997
Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicityA Hombach, T Tillmann, M Jensen, et al.
Lymphokine and Cytokine Research|April 1, 1992
Increased levels of circulating cytokines in patients with untreated Hodgkin's diseaseA Gause, S Keymis, R Scholz, et al.
Cancer Research|March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysisA Hombach, D Sent, C Schneider, et al.
Gastroenterology|October 10, 1997
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitopeA Hombach, C Heuser, R Sircar, et al.
Journal of Chromatography. A|January 23, 1999
Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phasesM Weitzhandler, D Farnan, J Horvath, et al.
Plos Neglected Tropical Diseases|February 10, 2025
Investigating the impact of Premolis semirufa caterpillar bristle toxins on human chondrocyte activation and inflammationCinthya Lais de Lima, Paula C Pohl, Isadora M Villas-Boas, et al.
ACS Synthetic Biology|April 14, 2016
CRISPR/Cas9 Based Genome Editing of Penicillium chrysogenumC Pohl, J A K W Kiel, A J M Driessen, et al.
Pageof 19